Materials and Methods
Immunization. BALB/c or (BAB14 × BRVR)F1 mice were immunized by two methods. Primary immunization consisted of an injection of 100/zg of B1355S in complete Freund's adjuvant. Hyperimmunization involved primary immunization followed by three injections of 2 × 109 Escherichia coli at 2-d intervals l mo later. Fusions were performed 5-7 d after final immunization.
Production of Hybridomas. The procedure used was essentially that ofGalfr~ et al. (16) . Briefly, l0 s spleen cells from dextran-immunized mice were fused with at least 10 ~ HGPRT-MPC11 (Hdex 1 and 3), NS1 (Hdex 2, 6, 9 and 31), or Sp2/O-Agl4 ( Hdex 11, 12, 14, 24, 25 , and 36) cells using polyethylene glycol (Carbowax 1500 [ 1,500 mol wt]; Fisher Scientific Co., Pittsburgh, PA). The cell lines were generously supplied by Dr. M. Scharff (Albert Einstein College of Medicine, New York), Dr. C. Milstein (Medical Research Council, Cambridge, England), and Dr. G. Kghler (Basel Institute for Immunology, Basel, Switzerland) (17) (18) (19) , respectively. After fusion, cells were grown in hypoxanthine, aminopterin, thymidine selection media (20) in 24-well culture plates. Dextran-binding proteins were detected either by isoelectric focusing or by radioimmunoassay. Hybrids were cloned in soft agar over 3T3 feeder layers (21) and grown in BALB/c mice as ascites tumours.
Dextrans. Native dextrans have been described previously (1) (2) (3) (4) (5) and <1% of units with three branch points in a row. Unbranched segments vary widely in length.
Quantitative Precipitin Assay. The procedure has been previously outlined (22) . A constant amount of antibody, 4-7.3 #g antibody nitrogen (AbN), was added to varying quantities, 0-60 #g, of dextran; the total volume was 280 or 400/11. After incubation for 1 h at 37°C, and 5-7 d at 4°C with daily mixing, AbN in the washed precipitates was determined by Ninhydrin assay. The precipitin patterns and the classification into groups were not affected by the total volume or amount of AbN chosen, and lower amounts of AbN permitted use of smaller quantities of scarce oligosaccharides in inhibition assays.
Amino Acid Sequences. VH amino acid sequences of MOPC104E, J558, and Hdex 1 through 10 have been reported previously (14, 23, 24) . The sequences of Hdex 11, 12, 14, 24, 25, 31 , and 36 will be published elsewhere. 2 Amino acid positions are denoted by sequential and homologized numbering (24) in square brackets [ ] to facilitate comparisons with other VH chains.
1 Abbreviations used in this paper: CDR, complementarity determining region; FR, framework region; Glc, glucose IdI, individual idiotype; IdX, cross-reactive idiotype. Amino acid code: A, Ala; R, Arg; N, Ash; D, Asp; C, Cys; Q, Gin; E, Glu; G, Gly; H, His; I, Ile; L, Leu; K, Lys; M, Met; F, Phe; P, Pro; S, Ser; T, Thr; W, Trp; Y, Tyr; and V, Val.
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Results
Quantitative Precipitin Assays. The results in Table I and Fig. 1 show the relationships among the hybridoma (Hdex) antibodies from quantitative precipitin assays with numerous dextrans. The maximum precipitation of any dextran (-to ++++) and the amount required for 50% of maximum precipitation relative to B1355S are given. When the antibodies are arranged in order of increasing cross reactivity, five groups are seen. Previously characterized mouse myeloma proteins CAL20 TEPC 1035, J558, and MOPC104E fit into groups 1, 3, and 5, respectively (10) (11) (12) . From Fig. 1 , it is apparent that all hybridoma antibodies react maximally and to similar extents with class II dextrans, B 1355S, B 1498S, and B 1501 S; the classification into groups therefore is based on the varying extents to which cross reactions with class I dextrans occur.
In group 1, CAL20 TEPC1035, and Hdex 12, 25, and 31, react with none of the class I dextrans. However, beginning with group 2, once a class I dextran shows some cross-reactivity, it continues to precipitate in all succeeding groups. Hdex 36 is precipitated by B742S, but this curve enters the antigen excess zone sooner than is seen with other antibodies binding this dextran. This is probably due to Hdex 36 being IgG3X, whereas all other Hdex antibodies are IgM)~. The three members of group 3, Hdex 6, 9, and J558, also react with B742S. In addition, proteins in this group cross-react somewhat with three or four other dextrans: Hdex 6 and 9 with B1299S, B1355L, and B1255, and J558 (10, 11) with B1299S, B1255, B1375, and B742L.
Group 4, Hdex 1, 3, and 24 are precipitated to greater extents by B742S, B 1299S, and B1355L. With Hdex 3 and 24, B1255 reacts almost as well; B1375, B1254S, and B742L react less strongly. With Hdex 1, B 1255 behaves more like B742L and B 1254S, and B 1375 is only slightly active.
Group 5 precipitates with all dextrans reactive in group 4, and is distinguished from group 4 primarily by the greater precipitating power of dextrans B 742S, B 1299S, B1355L, and B1255. This is seen most strikingly with Hdex 11 and 14; B1255 and B1355L appear somewhat less active with Hdex 2. Less strongly reacting dextrans include B1375 and B1254S, which behave similarly, followed in decreasing order of activity by B742L, B 1141, and possibly B 1501L.
The remaining class I dextrans B1498L, B1351S, B512, B1399, B1425, Bl142, B1424, and the synthetic dextran V39 do not react with any of the Hdex antibodies with which they were tested.
Dextran Structure and Reactivity. The structural compositions of these dextrans to the extent that they are currently known may be found in refs. 1-5. The three maximally reacting class II dextrans, B 1355S, B 1498S, and B 1501S, are similar in linkages and degrees of branching: 54-67% a(1 ~ 6) and 33-46% c~(1 --~ 3), with 9-11% of the c~(l ~ 3) at branch points (3); all are proposed to have an alternating t~(1 ~ 3), o~(l --~ 6) sequence (4, 5) .
Two strongly cross-reactive class I dextrans in groups 4 and 5, B1299S and B742S both have highly branched structures with 35% a(1 ~ 2) and 50% a(1 ~ 3) linkages at branch points, respectively (3). However, two other strongly reactive dextrans, B1355L and B1255, have infrequent branching (2, 3). B1355L, with ~5% a(1 --~ 3) branch points (3), appears similar to B512, which is nonreactive in all precipitin groups, and thus its reactivity is puzzling. It is known that B1355L is synthesized 
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Group I :~ H, hyperirnmunization; P, primary immunization. § Percent of maximum precipitation with any dextran relative to maximum precipitation with dextran B1355S. The very weakly reactive and nonreactive dextrans generally have low percentages of branched residues with the exception of Bl142 (3); its failure to react has been observed previously (26) and is not understood.
Little is known about the distribution of the side chains, i.e., the spacing of the "teeth" on the proposed comblike class I dextrans, which would provide the multivalent determinants for the cross reactions. Some of the apparent inconsistencies in
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Hdex I diluted 1/2 , 25p1, W. Discussion Quantitative precipitin studies, similar to those with blood group substances and monoclonal anti-I and anti-i sera (27) , reveal significant differences in combining site specificities among 12 mouse hybridoma antibodies to dextran B 1355S. The spectrum appears greater than that seen in 12 mouse hybridomas to dextran B512 (9), reflecting the greater structural complexity of B 1355S. However, immunization, fusion, screening, subcloning, and culturing procedures for obtaining hybridomas may affect the findings by favoring certain clones, perhaps those growing faster or secreting immu-noglobulins of higher affinity. Such factors could be responsible for the failure on immunization of mice with B1355S to obtain hybridoma antibodies cross reacting with B512, which have been seen in humans immunized with this dextran (6, 28, 29) . Thus, the five-group classification may not include the entire repertoire (30) .
The precipitation of all of the Hdex antibodies with class II dextrans suggests that the sequence of alternating a(1 ~ 6) and a(1 ~ 3)-linked glucoses is the preferred determinant. In rabbits injected with B1355S, two distinct populations of antibodies specific for the alternating sequence were seen, with the a(1 ~ 6) or the a(1 ~ 3) linkage being immunodominant (31) . Quantitative precipitin inhibition studies (unpublished) show that tri-and tetrasaccharides with alternating a(1 ~ 3) and a(1 ~ 6)-linked glucoses are the best inhibitors thus far found of the precipitation of the Hdex antibodies with B1355S. They are better than nigerosyl a(1 --~ 3)-linked oligosaccharides of the same size; the a(1 --9 6)-linked isomaltosyl series does not inhibit. Larger oligosaccharides, as well as alternating oligosaccharides with side chains, are needed for a more complete definition of the combining sites. CAL20 TEPC1035 (group 1) is inhibited best by panose, Glcal ~ 6Glca 1 ~ 4Glc (10), which does not inhibit any of the Hdex antibodies or MOPC104E. It was previously suggested (10) that the combining site of CAL20 TEPC1035 might be most specific for an unknown molecule containing a panose-like determinant with which class II dextrans cross react. Therefore, the CAL20 TEPC1035 combining site specificity differs from the group 1 Hdex antibody sites, although the precipitin patterns appear identical.
Inclusion within a group therefore implies similarity but not necessarily identity of binding specificity. Indeed, with the exception of group 1, in which the precipitation pattern of all proteins is indistinguishable, no other proteins show such identical binding specificities. Although one could legitimately consider each protein as a separate group, it may be more useful to cluster them into five groups of gradually increasing cross-reactivity patterns, if only to determine which structural features of the variable regions may be responsible for binding specificity.
As seen in Table II , the group 1 precipitin pattern is shared by three Hdex antibodies with very different amino acid sequences in the third hypervariable region (CDR3) and FR4. From the inhibition data, the combining sites are specific for the alternating a(1 --~ 3) and a(1 --~ 6) linkages, but precipitin analyses show that they cannot accommodate cross reacting determinants on class I dextrans; the other groups of Hdex antibodies also have sites specific for the alternating sequence with perhaps, a subsite that accommodates class I determinants. Conceivably, access to this subsite might be blocked by side chains of one or more amino acid substitutions through steric hindrance, conformational changes, or charge effects. For example, R 103 [99] in Hdex 12 (group 1), with a long positively charged side chain, replaces Y 103 [99] , found in all of the cross reactive Hdex antibodies. It is of interest that in sites of the serine proteases, the presence in elastase of valine and threonine instead of two glycines in chymotrypsin obstructs and thereby prevents hydrolysis of chymotrypsin substrates having bulky side chains (32) .
There are several instances in which proteins in different groups differ by only a single amino acid. Thus Hdex25 (group 1), J558 (group 3), and Hdex2 (group 5) have S, R, and N, respectively, at position 100 [96]; Hdex25 (group 1) and Hdex6 (group 3) differ at position I01 [97] with Y and H, respectively. Whereas these residues are obviously of importance to specificity, it is difficult to imagine how the group classification could depend exclusively on single amino acid substitutions in VH. The light chains, although )k, most probably contribute to blocking part of the site responsible for the various cross reactivities, but final conclusions must await sequencing of these chains.
All proteins with RY at positions 100, 101 [96, 97] are in groups 1 and 3, and all those with YD are in group 5. These residues are associated with IdI(J558) and IdI(MOPC 104E) determinants and binding specificity appears to correlate somewhat with these markers. That not every protein within a group shares the same DHencoded residues suggests that similar binding specificities can be generated in more than one way, rather than that these residues are unimportant.
Some variable region structures, however, do seem unimportant to the binding specificity. For example, NN, at positions 54, 55 [53, 54] with an associated carbohydrate side chain (14, 15) on N 55 [54] , is found on all proteins except Hdex 14 which has KK at these positions. The heavy chain of MOPC 104E differs from Hdex 14 only at these residues, and yet both proteins are in group 5. Jn regions also seem unrelated to binding patterns: J1 is found in four groups, J2 in two groups, and J3 and J4 occur only once each.
These findings clearly establish that relatively minor changes in Vn amino acid sequence are associated with major differences in binding specificity. The data presented here put in perspective the gaps in our understanding of the relationship of diversity to antibody site specificity and complementarity (33) .
Summary
The combining sites of 12 mouse hybridoma antibodies to dextran B1355S have been characterized by quantitative precipitin assay. All antibodies preferentially bind' the immunizing antigen B1355S and two other class II dextrans, B1498S and B1501S, but show substantial differences in the extents to which they cross react with class I dextrans, suggesting their clustering into five groups. Three myeloma proteins, CAL20 TEPC1035, J558, and MOPC104E, which bind dextran B1355S, each fall into a different group. There appears to be a substantial, but imperfect, correlation of DH region structure and individual idiotypic determinants with dextran binding patterns. Proteins with RY DH segments and IdI (J558) idiotypes are in groups 1 or 3, and proteins with YD DH segments and IdI (MOPC104E) idiotypes are exclusively in group 5. However, identical patterns of precipitin curves accompany very different sequences in CDR3. Antibodies of group 1, which react only with class II dextrans, differ the most in primary sequence, a finding suggesting that suhsites responsible for cross reactivity with class I dextrans may be blocked and that this may be effected by side chains of different amino acids. This finding delineates a new aspect of the relationship of variability in amino acid sequence to antibody complementarity.
